Improving Symptoms and Quality of Life in Chronic Heart Failure: Pilot Study (CASA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01581008 |
|
Recruitment Status :
Completed
First Posted : April 19, 2012
Results First Posted : November 11, 2014
Last Update Posted : August 31, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Chronic Heart Failure (CHF) | Other: Collaborative Care to Alleviate Symptoms and Adjust to Illness Behavioral: Psychospiritual | Not Applicable |
The investigators will examine the feasibility of two palliative care interventions designed to improve different facets of quality of life. Briefly, the two interventions are:
-
A palliative symptom management and psychosocial care intervention named Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) that includes
- evidence-based palliative symptom management of breathlessness, fatigue, and pain, provided by a nurse;
- a 6-session structured psychosocial care protocol targeting depression and adjustment to illness, supplemented by informal (family) caregiver assessment and support, provided by a social worker or psychologist; and
- brief weekly team meetings with the nurse, social worker/psychologist and a palliative care specialist, cardiologist, and primary care provider.
- A psychospiritual intervention that is home-based, self-guided, and requires minimal resources. It will be delivered in written modular form via US Mail along with brief weekly telephone support.
The specific aims of the study are to:
-
Examine intervention feasibility and determine preliminary estimates of intervention effect
- Determine patient participation rates and cohort retention
- Conduct a preliminary assessment of outcomes by measuring pre-post changes in quality of life, depressive symptoms, health status, life meaning, and spirituality.
- Obtain qualitative feedback from study participants, the persons providing the intervention, and providers/leaders in primary care, mental health, palliative care, chaplaincy, and hospital operations.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 31 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Implementing Collaborative Care to Alleviate Symptoms and Adjust to Heart Failure: A Pilot Study |
| Study Start Date : | October 2011 |
| Actual Primary Completion Date : | September 2012 |
| Actual Study Completion Date : | December 2012 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Collaborative Care to Alleviate Symptoms and Adjust to Illness
A palliative symptom management and psychosocial care intervention named Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) that includes (a) evidence-based palliative symptom management of breathlessness, fatigue, and pain, provided by a nurse; (b) a 6-session structured psychosocial care protocol targeting depression and adjustment to illness, supplemented by informal (family) caregiver assessment and support, provided by a social worker or psychologist; and (c) brief weekly team meetings with the nurse, social worker/psychologist and a palliative care specialist, cardiologist, and primary care provider.
|
Other: Collaborative Care to Alleviate Symptoms and Adjust to Illness
A palliative symptom management and psychosocial care intervention named Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) that includes (a) evidence-based palliative symptom management of breathlessness, fatigue, and pain, provided by a nurse; (b) a 6-session structured psychosocial care protocol targeting depression and adjustment to illness, supplemented by informal (family) caregiver assessment and support, provided by a social worker or psychologist; and (c) brief weekly team meetings with the nurse, social worker/psychologist and a palliative care specialist, cardiologist, and primary care provider.
Other Name: Palliative symptom management and psychosocial care |
|
Active Comparator: Psychospiritual
A psychospiritual intervention that is home-based, self-guided, and requires minimal resources. It will be delivered in written modular form via US Mail along with brief weekly telephone support.
|
Behavioral: Psychospiritual
A psychospiritual intervention that is home-based, self-guided, and requires minimal resources. It will be delivered in written modular form via US Mail along with brief weekly telephone support. |
- Cohort Retention [ Time Frame: 3 months ]Cohort retention will be determined by examining the proportion of patients who complete the final study visit (at 3-month follow-up) over the total number of patients enrolled in the study (including deceased and lost-to-follow-up). Our goal is an 80% retention rate for this pilot study.
- Was Depression Addressed? [ Time Frame: 3 months ]The Patient Health Questionnaire-9 (PHQ-9) rates nine DSM-IV criteria of depression on a 0 (not at all) to 3 (nearly every day) scale. Scale range is 0-27, with depression severity scored: 0-4 (none), 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), 20-27 (severe). The suicidal item is "thoughts that you would be better off dead, or of hurting yourself in some way?"
- Participation Rates [ Time Frame: 7 months ]The investigators will use a CONSORT diagram to display participant flow, and determine how many of those who were approached enrolled in the trial.
- Adherence to the Study Protocol (CASA Arm Only) [ Time Frame: 3 months ]
The investigators will calculate percentage adherence to pre-specified tasks on the intervention protocol, such as:
- how often is depression addressed with a treatment plan?
- how often are care team recommendations placed as orders in the medical record?
- how often are orders completed?
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- eligible veterans from the Denver VAMC will have a prior primary discharge diagnosis of heart failure in the last year,
- be at least 18 years of age, able to read and understand English,
- have consistent access to a telephone
-
at least one of the following:
- Kansas City Cardiomyopathy Questionnaire (KCCQ) score less than or equal to 60;
- a second hospitalization for with a primary discharge diagnosis of heart failure in the last year;
- taking at least 80 mg oral furosemide (or equivalent) daily in a single or divided dose for at least 2 weeks;
- BNP greater than or equal to 250 or NT-proBNP greater than or equal to 1000; or
- estimated creatinine clearance 30-80 mL/min.
Exclusion Criteria:
- previous diagnosis of dementia;
- active substance abuse, defined as an AUDIT-C score greater than 7, two positive responses on substance abuse screening questions, or medical records indicating active substance abuse or dependence;
- comorbid metastatic cancer, given the focus on heart failure palliative care;
- nursing home resident; and
- diagnosis of bipolar disorder or schizophrenia.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01581008
| United States, Colorado | |
| VA Eastern Colorado Health Care System, Denver, CO | |
| Denver, Colorado, United States, 80220 | |
| Principal Investigator: | David Bekelman, MD MPH | VA Eastern Colorado Health Care System, Denver, CO |
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT01581008 |
| Other Study ID Numbers: |
RRP 11-239 CRICC Pilot ( Other Grant/Funding Number: Denver REAP (CRICC) Pilot Grant ) |
| First Posted: | April 19, 2012 Key Record Dates |
| Results First Posted: | November 11, 2014 |
| Last Update Posted: | August 31, 2018 |
| Last Verified: | August 2018 |
|
palliative care heart failure delivery of health care |
|
Heart Failure Heart Diseases Cardiovascular Diseases |

